PT0141 (Bremelanotide) is a synthetic cyclic peptide analog supplied as a high-purity lyophilized compound intended exclusively for laboratory research use by qualified professionals. Manufactured under controlled conditions to ensure batch consistency, analytical reliability, and stability.
For laboratory research use only.
Available concentrations: 10 mg
Peptide Type: Synthetic cyclic peptide
Peptide Class: Melanocortin receptor agonist analog
Structural Type: Cyclic heptapeptide derivative
Source: Synthetic (laboratory-produced)
Physical Form: Lyophilized powder
Purity: >99% (HPLC)
PT0141 is utilized in preclinical and experimental research settings investigating:
Melanocortin receptor signaling pathways (MC3R, MC4R)
Central nervous system peptide signaling
Neuroendocrine regulation and neurotransmitter modulation
Sexual behavior and arousal signaling pathways in experimental models
Hypothalamic and limbic system interactions
Peptide-receptor binding dynamics and downstream signaling cascades
Research involving PT-141 focuses on mechanistic exploration of melanocortin-mediated pathways, receptor activation profiles, and central signaling effects in in vitro and animal models. Research applications are limited to biological pathway analysis and experimental modeling, not therapeutic use.
Storage Conditions: 2–8 °C, protected from light
Stability: Lyophilized format supports extended stability when stored under recommended conditions
Reconstitution: For laboratory research protocols only, using appropriate sterile laboratory techniques
